°£¼¼Æ÷¾Ï ȯÀÚ¿¡¼ Ç÷û Ç÷°ü³»ÇǼ¼Æ÷¼ºÀåÀÎÀÚ¿Í Á¾¾çÀÇ ¹Ì¼¼ Ç÷°ü ħ¹ü
Serum Vascular Endothelial Growth Factor (VEGF) and Microvessel Tumor Invasion in Hepatocellular Carcinomas
È«¼º¿ì, Ȳµ¿Èñ, ¹éÀοí, ÀÌÇõ»ó,
¼Ò¼Ó »ó¼¼Á¤º¸
È«¼º¿ì ( Hong Seong-Woo )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ¼¿ï¹éº´¿ø ¿Ü°úÇб³½Ç
Ȳµ¿Èñ ( Whang Dong-Hee )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ¼¿ï¹éº´¿ø Áø´Ü°Ë»çÀÇÇб³½Ç
¹éÀοí ( Paik In-Wook )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ¼¿ï¹éº´¿ø ¿Ü°úÇб³½Ç
ÀÌÇõ»ó ( Lee Hyuck-Sang )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ¼¿ï¹éº´¿ø ¿Ü°úÇб³½Ç
KMID : 0371320030640030224
Abstract
PURPOSE: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor in a number of cancers. The aim of this study was to evaluate the clinical significance of the serum level of VEGF in hepatocellular carcinoma (HCC) patients.
METHODS: Serum VEGF was measured by an enzyme linked immunosorbent assay (ELISA) method. The correlation between serum VEGF level and clinico-pathological data of HCC patients were evaluated.
RESULTS: The serum VEGF levels significantly increased with increasing tumor size and platelets count. The mean serum VEGF level in HCC patients with microvessel tumor invasion was higher than in those without microvessel tumor invasion.
CONCLUSION: A high serum VEGF level may be an indicator of tumor progression and an important predictor of microvessel tumor invasion.
Å°¿öµå
Ç÷°ü³»ÇǼºÀåÀÎÀÚ;°£¼¼Æ÷¾Ï;Á¾¾çÀÇ ¹Ì¼¼Ç÷°ü ħ¹ü
Vascular endothelial growth factor;Hepatocellular carcinoma;Microvessel tumor invasion
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸